CARDIFF, Calif. (AP) — CARDIFF, Calif. (AP) — Viracta Therapeutics, Inc. (VIRX) on Monday reported a loss of $10.3 million in its fourth quarter.
On a per-share basis, the Cardiff, California-based company said it had a loss of 27 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
For the year, the company reported a loss of $49.2 million, or $1.30 per share.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIRX at https://www.zacks.com/ap/VIRX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.